Krüppel-like factors KLF2 and 6 and Ki-67 are direct targets of zoledronic acid in MCF-7 cellsEBERT, Regina; ZECK, Sabine; MEISSNER-WEIGL, Jutta et al.Bone (New York, NY). 2012, Vol 50, Num 3, pp 723-732, issn 8756-3282, 10 p.Article

Zoledronic acid in treatment of bone lesions by Langerhans cell histiocytosisMONTELLA, Liliana; MEROLA, Carmela; MEROLA, Geraldina et al.Journal of bone and mineral metabolism (English ed.). 2009, Vol 27, Num 1, pp 110-113, issn 0914-8779, 4 p.Article

Zoledronic acid results in better health-related quality of life following hip fracture: the HORIZON: Recurrent Fracture TrialADACHI, J. D; LYLES, K. W; BUCCI-RECHTWEG, C et al.Osteoporosis international. 2011, Vol 22, Num 9, pp 2539-2549, issn 0937-941X, 11 p.Article

A single dose of zoledronic acid reverses the deleterious effects of glucocorticoids on titanium implant osseointegrationCARVAS, J. S. B; PEREIRA, R. M. R; CAPARBO, V. F et al.Osteoporosis international. 2010, Vol 21, Num 10, pp 1723-1729, issn 0937-941X, 7 p.Article

Association between timing of zoledronic acid infusion and hip fracture healingCOLON-EMERIC, C; NORDSLETTEN, L; HYLDSTRUP, L et al.Osteoporosis international. 2011, Vol 22, Num 8, pp 2329-2336, issn 0937-941X, 8 p.Article

Flare-up of hand osteoarthritis caused by zoledronic acid infusionWERNER DE CASTRO, G. R; NEVES, F. S; DE MAGALHAES SOUZA FIALHO, S. C et al.Osteoporosis international. 2010, Vol 21, Num 9, pp 1617-1619, issn 0937-941X, 3 p.Article

Pharmacological therapy of Paget's and other metabolic bone diseasesHOSKING, David.Bone (New York, NY). 2006, Vol 38, Num 2, issn 8756-3282, S3-S7, SUP2Conference Paper

Short-courses of dexamethasone abolish bisphosphonate-induced reductions in bone toughnessLUO, Tianyi D; ALLEN, Matthew R.Bone (New York, NY). 2013, Vol 56, Num 1, pp 199-203, issn 8756-3282, 5 p.Article

Health-related quality of life and treatment of postmenopausal osteoporosis: Results from the HORIZON-PFTSAMBROOK, Philip N; SILVERMAN, Stuart L; CAULEY, Jane A et al.Bone (New York, NY). 2011, Vol 48, Num 6, pp 1298-1304, issn 8756-3282, 7 p.Article

Determination of rat vertebral bone compressive fatigue properties in untreated intact rats and zoledronic-acid-treated, ovariectomized ratsBROUWERS, J. E. M; RUCHELSMAN, M; RIETBERGEN, B. V et al.Osteoporosis international. 2009, Vol 20, Num 8, pp 1377-1384, issn 0937-941X, 8 p.Article

Activation of p38 MAPK-regulated Bcl-xL signaling increases survival against zoledronic acid-induced apoptosis in osteoclast precursorsTAI, Ta-Wei; SU, Fong-Chin; CHEN, Ching-Yu et al.Bone (New York, NY). 2014, Vol 67, pp 166-174, issn 8756-3282, 9 p.Article

The effects of intravenous zoledronic acid in Chinese women with postmenopausal osteoporosisHWANG, Jawl-Shan; CHIN, Lin-Show; CHEN, Jung-Fu et al.Journal of bone and mineral metabolism (English ed.). 2011, Vol 29, Num 3, pp 328-333, issn 0914-8779, 6 p.Article

Serum homocysteine, folate and vitamin B₁₂ in patients with Paget's disease of bone: the effect of zoledronic acidPOLYZOS, Stergios A; ANASTASILAKIS, Athanasios D; ZAFEIRIADOU, Efthimia et al.Journal of bone and mineral metabolism (English ed.). 2010, Vol 28, Num 3, pp 314-319, issn 0914-8779, 6 p.Article

Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronateSAMBROOK, Philip N; ROUX, Christian; DEVOGELAER, Jean-Pierre et al.Bone (New York, NY). 2012, Vol 50, Num 1, pp 289-295, issn 8756-3282, 7 p.Article

Nanotechnologies to use zoledronic acid as a potent antitumoral agentSALZANO, G; MARRA, M; LEONETTI, C et al.Journal of drug delivery science and technology. 2011, Vol 21, Num 3, pp 283-284, issn 1773-2247, 2 p.Article

A single dose zoledronic acid enhances pin fixation in high tibial osteotomy using the hemicallotasis technique. A double-blind placebo controlled randomized study in 46 patientsHARDING, Anna Kajsa; TOKSVIG-LARSEN, Sören; TÄGIL, Magnus et al.Bone (New York, NY). 2010, Vol 46, Num 3, pp 649-654, issn 8756-3282, 6 p.Article

The impact of zoledronic acid on regenerate and native bone after consolidation and removal of the external fixator: An animal model studySAGHIEH, Said; KHOURY, Nabil J; TAWIL, Ayman et al.Bone (New York, NY). 2010, Vol 46, Num 2, pp 363-368, issn 8756-3282, 6 p.Article

Clinical study evaluating the effect of bevacizumab on the severity of zoledronic acid-related osteonecrosis of the jaw in cancer patientsLESCAILLE, Géraldine; COUDERT, Amélie E; SPANO, Jean-Philippe et al.Bone (New York, NY). 2014, Vol 58, pp 103-107, issn 8756-3282, 5 p.Article

Molecular interactions between zoledronic acid and bone: An in vitro Raman microspectroscopic studyJUILLARD, Audrey; FALGAYRAC, Guillaume; CORTET, Bernard et al.Bone (New York, NY). 2010, Vol 47, Num 5, pp 895-904, issn 8756-3282, 10 p.Article

Combined therapy of Sr-89 and zoledronic acid in patients with painful bone metastasesSTORTO, Giovanni; KLAIN, Michele; PAONE, Gaetano et al.Bone (New York, NY). 2006, Vol 39, Num 1, pp 35-41, issn 8756-3282, 7 p.Article

Effect of zoledronic acid on incorporation of a bioceramic bone graft substituteVÄLIMÄKI, Ville-Valtteri; MORITZ, Niko; YRJANS, Jessica J et al.Bone (New York, NY). 2006, Vol 38, Num 3, pp 432-443, issn 8756-3282, 12 p.Article

Zoledronic acid and renal toxicity : Data from French adverse effect reporting databaseMUNIER, Aline; GRAS, Valerie; ANDREJAK, Michel et al.The Annals of pharmacotherapy. 2005, Vol 39, Num 7-8, pp 1194-1197, issn 1060-0280, 4 p.Article

Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesionROSEN, Lee S; GORDON, David H; COLEMAN, Robert E et al.Cancer. 2004, Vol 100, Num 1, pp 36-43, issn 0008-543X, 8 p.Article

Possible delayed onset of osteonecrosis of the jaw in association with zoledronic acidBORRAS-BLASCO, J; ROSIQUE-ROBLES, D; GINER-MARCO, V et al.Journal of clinical pharmacy and therapeutics (Print). 2007, Vol 32, Num 6, pp 651-654, issn 0269-4727, 4 p.Article

Effects of Intravenous Zoledronic Acid Plus Subcutaneous Teriparatide [rhPTH(1―34)] in Postmenopausal OsteoporosisCOSMAN, Felicia; FINK ERIKSEN, Erik; BUCCI-RECHTWEG, Christina et al.Journal of bone and mineral research (Print). 2011, Vol 26, Num 3, pp 503-511, issn 0884-0431, 9 p.Article